Cargando…
The Immunogenicity and Safety of Mycobacterium tuberculosis-mosR-Based Double Deletion Strain in Mice
Mycobacterium tuberculosis (M. tuberculosis) remains a significant global health threat, accounting for ~1.7 million deaths annually. The efficacy of the current vaccine, M. bovis BCG, ranges from 0 to 80% in children and does not prevent adulthood tuberculosis. We explored the immune profile and sa...
Autores principales: | Hildebrand, Rachel E., Hansen, Chungyi, Kingstad-Bakke, Brock, Wu, Chia-Wei, Suresh, Marulasiddappa, Talaat, Adel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459135/ https://www.ncbi.nlm.nih.gov/pubmed/37630665 http://dx.doi.org/10.3390/microorganisms11082105 |
Ejemplares similares
-
WebRTC-based MOSR remote control of mobile manipulators
por: Tiberkak, Allal, et al.
Publicado: (2023) -
A DNA Prime and MVA Boost Strategy Provides a Robust Immunity against Infectious Bronchitis Virus in Chickens
por: Chandrasekar, Shaswath S., et al.
Publicado: (2023) -
MOSR and NDHA Genes Comprising G-Quadruplex as Promising Therapeutic Targets against Mycobacterium tuberculosis: Molecular Recognition by Mitoxantrone Suppresses Replication and Gene Regulation
por: Dey, Arpita, et al.
Publicado: (2023) -
Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
por: Mergaert, Aisha M., et al.
Publicado: (2022) -
Localized and Systemic Immune Responses against SARS-CoV-2 Following Mucosal Immunization
por: Chandrasekar, Shaswath S., et al.
Publicado: (2021)